A cancer vaccine consisting of irradiated non-small cell lung cancer cells, manipulated to express and secrete heat shock protein gp96-Ig fusion protein, with potential antineoplastic activity. Vaccination with gp96-Ig fusion protein-expressing non-small cell lung cancer cell vaccine may elicit a cytotoxic T cell response against non-small lung cancer cells. Monomorphic heat shock protein gp96 participates in the major histocompatibility complex class I-restricted antigen presentation pathway.
Leave a Comment
You must be logged in to post a comment.